Bioequivalence of Generic and Brand Name Clozapine in Korean Schizophrenic Patients: A Randomized, Two-Period, Crossover Study

OBJECTIVE: Clozapine is the treatment of choice for refractory schizophrenia. The aim of this study was to compare the pharmacokinetics of the brand name (Clozaril) formulation and a generic formulation (Clzapine) of clozapine in Korean schizophrenic patients. METHODS: A prospective, randomized, cro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Psychiatry Investig
Autori principali: Woo, Young Sup, Wang, Hee-Ryung, Yoon, Bo-Hyun, Lee, Sang-Yeol, Lee, Kwang Hun, Seo, Jeong Seok, Bahk, Won-Myong
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Neuropsychiatric Association 2015
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4504918/
https://ncbi.nlm.nih.gov/pubmed/26207129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4306/pi.2015.12.3.356
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi